Shuttle Pharmaceuticals Holdings (SHPH) Other Accumulated Expenses (2021 - 2022)

Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Other Accumulated Expenses of $18904.0 in Q3 2022, up 3324.64% quarter-over-quarter from $552.0 in Q4 2021.

Shuttle Pharmaceuticals Holdings (SHPH) Other Accumulated Expenses (2021 - 2022) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $18904.0 for Q3 2022.

  • In Q3 2022, Other Accumulated Expenses changed N/A year-over-year to $18904.0; the TTM figure through Sep 2022 stood at $18904.0 (changed N/A YoY), while the FY2021 annual figure was $552.0, changed N/A from the prior year.
  • Other Accumulated Expenses was $18904.0 for Q3 2022 at Shuttle Pharmaceuticals Holdings, up from $552.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $18904.0 in Q3 2022 to a low of $552.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Shuttle Pharmaceuticals Holdings 2.17 Mn 1.11 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 18,904.00
Dec 31, 2021 552.00